• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪用阿地普明注射液的制备及基于药代动力学-药效学模型的给药方案

Preparation of Aditoprim Injection against in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling.

作者信息

Qu Wei, Dong Mengxiao, Pan Yuanhu, Xie Shuyu, Yuan Zonghui, Huang Lingli

机构信息

National Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, Wuhan 430070, China.

MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.

出版信息

Pharmaceutics. 2022 Mar 28;14(4):730. doi: 10.3390/pharmaceutics14040730.

DOI:10.3390/pharmaceutics14040730
PMID:35456564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9028088/
Abstract

In order to effectively treat the infection of and reduce the emergence of drug-resistant bacteria, an aditoprim (ADP) injection was developed in this study. The pharmaceutical property investigation results demonstrated that ADP injection was a clear yellow liquid with 10 g ADP distributing in every 100 mL solution uniformly. Its pH value and drug content were around 6.20 and 99.35100.40%, respectively. And quality assessment preliminarily indicated its reliable quality and stability. Additionally, the bronchoalveolar lavage fluid method was first applied to evaluate accurate ADP concentration at infection site in this study. Through pharmacodynamic assay, the MIC, MBC and MPC of ADP against CVCC 607 was 2 μg/mL, 4 μg/mL and 12.8 μg/mL, respectively. The bacteria growth inhibition curves showed that ADP was a concentration-dependent antibacterial drug, and the PK-PD model parameter of AUC/MIC was selected. The pharmacokinetic parameters of alveolar fluid evaluated by WinNonlin software revealed similar pharmacokinetic process of ADP in healthy pigs and infected pigs. Combined with pharmacokinetics-pharmacodynamics (PK-PD) modeling, the dosage regimen of 35 days with an interval of 12 h at 4.10 mg/kg or 5.91 mg/kg could be adopted to treat the infection of . Consequently, this ADP injection with a multi-dose protocol would be a promising antimicrobial product for efficient treatment of infection of pigs.

摘要

为有效治疗[感染类型]感染并减少耐药菌的出现,本研究开发了一种阿地普明(ADP)注射液。药物性质研究结果表明,ADP注射液为澄清黄色液体,每100 mL溶液中均匀分布有10 g ADP。其pH值和药物含量分别约为6.20和99.35%~100.40%。质量评估初步表明其质量可靠且稳定。此外,本研究首次应用支气管肺泡灌洗法评估感染部位的准确ADP浓度。通过药效学测定,ADP对CVCC 607的MIC、MBC和MPC分别为2 μg/mL、4 μg/mL和12.8 μg/mL。细菌生长抑制曲线表明,ADP是一种浓度依赖性抗菌药物,并选择了AUC/MIC的PK-PD模型参数。通过WinNonlin软件评估的肺泡液药代动力学参数显示,ADP在健康猪和感染猪中的药代动力学过程相似。结合药代动力学-药效学(PK-PD)建模,可采用4.10 mg/kg或5.91 mg/kg、每12 h一次、持续3至5天的给药方案来治疗[感染类型]感染。因此,这种多剂量方案的ADP注射液将是一种有前景的抗菌产品,可有效治疗猪的[感染类型]感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/3971eb7ff0d5/pharmaceutics-14-00730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/cad399cbaa24/pharmaceutics-14-00730-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/12f74616f9dd/pharmaceutics-14-00730-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/58b1bd83dc84/pharmaceutics-14-00730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/c36f04c4bd95/pharmaceutics-14-00730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/3971eb7ff0d5/pharmaceutics-14-00730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/cad399cbaa24/pharmaceutics-14-00730-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/12f74616f9dd/pharmaceutics-14-00730-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/58b1bd83dc84/pharmaceutics-14-00730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/c36f04c4bd95/pharmaceutics-14-00730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f80/9028088/3971eb7ff0d5/pharmaceutics-14-00730-g003.jpg

相似文献

1
Preparation of Aditoprim Injection against in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling.猪用阿地普明注射液的制备及基于药代动力学-药效学模型的给药方案
Pharmaceutics. 2022 Mar 28;14(4):730. doi: 10.3390/pharmaceutics14040730.
2
Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.泰乐菌素对猪源猪链球菌的药代动力学-药效学建模
BMC Vet Res. 2018 Oct 24;14(1):319. doi: 10.1186/s12917-018-1645-3.
3
A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against .一种基于生理学的药代动力学/药效学模型,用于确定阿地普明的给药方案和停药间隔时间 。 (原文最后“against.”后面内容缺失,翻译到此为止)
Front Pharmacol. 2024 Apr 17;15:1378034. doi: 10.3389/fphar.2024.1378034. eCollection 2024.
4
Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.联合使用阿地普林和磺胺甲恶唑对猪源大肠杆菌的抗菌活性及基于药代动力学-药效学模型的给药方案。
J Vet Pharmacol Ther. 2022 Jan;45(1):133-145. doi: 10.1111/jvp.13006. Epub 2021 Aug 26.
5
Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine infection.制定盐酸头孢噻呋油混悬注射液治疗猪感染的合理剂量方案的药代动力学-药效学(PK-PD)模型。
J Vet Sci. 2021 Nov;22(6):e41. doi: 10.4142/jvs.2021.22.e41.
6
PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against in Piglets.乙酰吉他霉素对仔猪的药代动力学-药效学建模及最佳给药方案
Antibiotics (Basel). 2022 Feb 21;11(2):283. doi: 10.3390/antibiotics11020283.
7
PK-PD Integration Modeling and Cutoff Value of Florfenicol against in Pigs.氟苯尼考对猪的药代动力学-药效学整合模型及截断值
Front Pharmacol. 2018 Jan 17;9:2. doi: 10.3389/fphar.2018.00002. eCollection 2018.
8
Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against in Pigs.氟苯尼考在猪体内的滑膜和全身药代动力学以及针对[具体病原体未给出]的PK/PD整合
Pharmaceutics. 2022 Jan 3;14(1):109. doi: 10.3390/pharmaceutics14010109.
9
Determination of Susceptibility Breakpoint for Cefquinome against in Pigs.头孢喹肟对猪源[具体细菌名称未给出]的药敏断点测定
Antibiotics (Basel). 2021 Aug 9;10(8):958. doi: 10.3390/antibiotics10080958.
10
Integration of PK/PD for dose optimization of aditoprim against Trueperella pyogenes causing endometritis in bovines.整合药代动力学/药效学以优化阿地普明治疗牛化脓隐秘杆菌引起的子宫内膜炎的剂量。
Microb Pathog. 2020 May;142:104097. doi: 10.1016/j.micpath.2020.104097. Epub 2020 Feb 24.

引用本文的文献

1
A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against .一种基于生理学的药代动力学/药效学模型,用于确定阿地普明的给药方案和停药间隔时间 。 (原文最后“against.”后面内容缺失,翻译到此为止)
Front Pharmacol. 2024 Apr 17;15:1378034. doi: 10.3389/fphar.2024.1378034. eCollection 2024.

本文引用的文献

1
Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against in Pigs.氟苯尼考在猪体内的滑膜和全身药代动力学以及针对[具体病原体未给出]的PK/PD整合
Pharmaceutics. 2022 Jan 3;14(1):109. doi: 10.3390/pharmaceutics14010109.
2
Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.联合使用阿地普林和磺胺甲恶唑对猪源大肠杆菌的抗菌活性及基于药代动力学-药效学模型的给药方案。
J Vet Pharmacol Ther. 2022 Jan;45(1):133-145. doi: 10.1111/jvp.13006. Epub 2021 Aug 26.
3
The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal.
兽医学中抗菌药物的药代动力学/药效学模式:最新进展与批判性评估
J Vet Pharmacol Ther. 2021 Mar;44(2):172-200. doi: 10.1111/jvp.12917. Epub 2020 Oct 21.
4
Integration of PK/PD for dose optimization of aditoprim against Trueperella pyogenes causing endometritis in bovines.整合药代动力学/药效学以优化阿地普明治疗牛化脓隐秘杆菌引起的子宫内膜炎的剂量。
Microb Pathog. 2020 May;142:104097. doi: 10.1016/j.micpath.2020.104097. Epub 2020 Feb 24.
5
Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.泰乐菌素对猪源猪链球菌的药代动力学-药效学建模
BMC Vet Res. 2018 Oct 24;14(1):319. doi: 10.1186/s12917-018-1645-3.
6
Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung.考虑药代动力学效应部位以估计药物暴露:肺中的抗生素浓度。
Curr Opin Pharmacol. 2017 Oct;36:114-123. doi: 10.1016/j.coph.2017.09.019. Epub 2017 Oct 31.
7
The antibacterial activities of aditoprim and its efficacy in the treatment of swine streptococcosis.阿地普林的抗菌活性及其在猪链球菌病治疗中的疗效。
Sci Rep. 2017 Feb 1;7:41370. doi: 10.1038/srep41370.
8
Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study.使用热敏聚合物对上尿路进行丝裂霉素C缓释制剂的临床前研究。
Urology. 2017 Jan;99:270-277. doi: 10.1016/j.urology.2016.09.039. Epub 2016 Oct 5.
9
Simultaneous determination of aditoprim and its three major metabolites in pigs, broilers and carp tissues, and its application in tissue distribution and depletion studies.同时测定猪、肉鸡和鲤鱼组织中阿地普明及其三种主要代谢物,并将其应用于组织分布和消除研究。
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Aug;33(8):1299-311. doi: 10.1080/19440049.2016.1200751. Epub 2016 Jul 27.
10
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.注射恩诺沙星、氟苯尼考、头孢噻呋或泰拉霉素的犊牛肺上皮衬液和间质液中活性药物浓度的比较。
PLoS One. 2016 Feb 12;11(2):e0149100. doi: 10.1371/journal.pone.0149100. eCollection 2016.